• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of March 6, 2013

  • Print
  • Share
  • E-mail

Event Detail

Event ID 64198
Product Type Drugs
Status Ongoing
Recalling Firm Pacira Pharmaceuticals, Inc.
City San Diego
State CA
Country US
Voluntary/Mandated Voluntary: Firm Initiated
Recall Initiation Date 2012-12-17
Initial Firm Notification of
Consignee or Public
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution Pattern Nationwide distribution: AZ, DC, FL, GA, MA, NJ, NY, OH, and TX.

Product Detail

Product Description Code Info Classification Reason for Recall Product Quantity Recall Number
EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA Lot #11-2005 Control #23542 Manufacture Date: 05Dec11 2011-L-009 Class II Subpotent; bupivacaine 324 vials D-168-2013